Crystal structure of besifloxacin hydrochloride, C19H22ClFN3O3Cl

被引:2
|
作者
Kaduk, James A. [1 ,2 ]
Gates-Rector, Stacy [3 ]
Blanton, Thomas N. [3 ]
机构
[1] IIT, 3101 S Dearborn St, Chicago, IL 60616 USA
[2] North Cent Coll, 131 S Loomis St, Naperville, IL 60540 USA
[3] ICDD, 12 Campus Blvd, Newtown Sq, PA 19073 USA
关键词
besifloxacin; Besivance; powder diffraction; Rietveld refinement; density functional theory; DENSITY;
D O I
10.1017/S0885715622000586
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The crystal structure of besifloxacin hydrochloride has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density functional theory techniques. Besifloxacin hydrochloride crystallizes in space group P1 (#1) with a = 5.36596(8), b = 10.3234(4), c = 17.9673(14) angstrom, alpha = 98.122(5), beta = 92.9395(9), gamma = 96.1135(3)degrees, V = 977.483(13) angstrom(3), and Z = 2. The crystal structure is approximately centrosymmetric. Strong N-HMIDLINE HORIZONTAL ELLIPSISCl hydrogen bonds form a corrugated ladder-like chain along the a-axis. The carboxylic acid group in each independent cation acts as the donor in a strong intramolecular O-HMIDLINE HORIZONTAL ELLIPSISO hydrogen bond to an adjacent carbonyl group. The powder pattern has been submitted to ICDD for inclusion in the Powder Diffraction File (TM) (PDF (R)).
引用
收藏
页码:43 / 52
页数:10
相关论文
共 50 条
  • [1] Crystal structure of oxybutynin hydrochloride hemihydrate, C22H32NO3Cl(H2O)0.5
    Kaduk, James A.
    Boaz, Nicholas C.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2019, 34 (01) : 50 - 58
  • [2] Crystal structure of levalbuterol hydrochloride polymorph A (Xopenex), C13H22NO3Cl
    Kaduk, James A.
    Zhong, Kai
    Blanton, Thomas N.
    Gates, Stacy
    POWDER DIFFRACTION, 2015, 30 (02) : 158 - 162
  • [3] Crystal structure of rilpivirine hydrochloride, N6H19C22Cl
    Buikin, Petr
    Korlyukov, Alexander
    Kulikova, Elizaveta
    Novikov, Roman
    Vologzhanina, Anna
    POWDER DIFFRACTION, 2024, 39 (03) : 151 - 158
  • [4] Crystal structure of encorafenib, C22H27ClFN7O4S
    Kaduk, James A.
    Dosen, Anja Vieira
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2023, 38 (02) : 145 - 151
  • [5] Crystal structure of ractopamine hydrochloride, C18H24NO3Cl
    Scherry, Colin W.
    Boaz, Nicholas C.
    Kaduk, James A.
    Dosen, Anja
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2024, 39 (02) : 94 - 104
  • [6] Crystal structure of alfuzosin hydrochloride, C19H28N5O4Cl
    Kaduk, James A.
    POWDER DIFFRACTION, 2022, 37 (03) : 171 - 182
  • [7] Crystal structure of (E)-doxepin hydrochloride, C19H22NOCl
    Hong, Jerry
    Golab, Joseph T.
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2021, 36 (01) : 43 - 49
  • [9] Crystal structure of songorine chloride trihydrate, [C22H32NO3]Cl • 3H20
    Fan, Zhi-Chao
    Zhang, Zhi-Qi
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2008, 223 (02): : 111 - 113
  • [10] Crystal structure of racemic benserazide hydrochloride Form I, C10H16N3O5Cl
    Kaduk, James A.
    Dosen, Anja
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2024,